<DOC>
	<DOCNO>NCT01810380</DOCNO>
	<brief_summary>To determine efficacy safety brexpiprazole treatment adult experience acute episode schizophrenia .</brief_summary>
	<brief_title>Brexpiprazole Patients With Acute Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Brexpiprazole</mesh_term>
	<criteria>The patient schizophrenia , diagnose accord DSMIVTR™ confirm Mini International Neuropsychiatric Interview ( MINI ) . The patient acute exacerbation psychotic symptom mark deterioration usual function . The patient willing hospitalise Screening Visit Week 6 . The patient benefit hospitalisation continue hospitalisation treatment current acute relapse schizophrenia study entry . The patient history relapse and/or exacerbation symptom receive antipsychotic treatment , exclude current episode . The patient agree protocoldefined use effective contraception . The patient current Axis I diagnosis ( DSMIVTR™ criterion ) schizophrenia establish primary diagnosis . The patient suffers current Axis II diagnosis ( DSMIVTR™ criterion ) . The patient suffers mental retardation , organic mental disorder , mental disorder due general medical condition ( DSMIVTR™ criterion ) . The patient , opinion investigator accord Columbia Suicide Severity Rating Scale ( CSSRS ) , significant risk suicide . The patient clinically significant tardive dyskinesia severe akathisia enrolment . The patient history neuroleptic malignant syndrome . The patient relevant medical history current presence systemic disease . The patient , Screening Visit abnormal ECG abnormal ECG test , investigator 's opinion , clinically significant . The patient history cancer , basal cell Stage 1 squamous cell carcinoma skin , remission &gt; 5 year prior first dose brexpiprazole . The patient , investigator 's opinion , unlikely comply protocol unsuitable reason . Other inclusion exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>